Nasdaq:US$12.13 (-0.47) | HKEX:HK$19.40 (+0.00) | AIM:£2.00 (+0)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases | 19 Apr 2023

AACR 2023: HMPL-453, a highly selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays potent activity in FGFR-altered tumor models